J05AX Other antivirals
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 13 drugs in this drug class and its subclasses.
- 13 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
-
J05AX Other antivirals 13 drugs
- J05AX05 Inosine pranobex 1 drug
- J05AX07 Enfuvirtide 1 drug
- J05AX09 Maraviroc 2 drugs
- J05AX10 Maribavir 1 drug
- J05AX18 Letermovir 2 drugs
- J05AX24 Tecovirimat 1 drug
- J05AX25 Baloxavir marboxil 1 drug
- J05AX28 Bulevirtide 1 drug
- J05AX29 Fostemsavir 1 drug
- J05AX31 Lenacapavir 2 drugs
-
J05AX Other antivirals 13 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Baloxavir marboxil 1 drug
- Bulevirtide (bulevirtide acetate) 1 drug
- Enfuvirtide 1 drug
- Fostemsavir (fostemsavir tromethamine) 1 drug
- Inosine pranobex 1 drug
- Lenacapavir (lenacapavir sodium) 2 drugs
- Letermovir 2 drugs
- Maraviroc 2 drugs
- Maribavir 1 drug
- Tecovirimat (tecovirimat monohydrate) 1 drug
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Celsentri PM (J05AX09 Maraviroc) | prescription (Rx) |
| Fuzeon PM (J05AX07 Enfuvirtide) | prescription (Rx) |
| Hepcludex (J05AX28 Bulevirtide) | prescription (Rx) |
| Imunovir PM (J05AX05 Inosine pranobex) | prescription (Rx) |
| Livtencity PM (J05AX10 Maribavir) | prescription (Rx) |
| Lupin-Letermovir PM (J05AX18 Letermovir) | prescription (Rx) |
| Prevymis PM (J05AX18 Letermovir) | prescription (Rx) |
| Rukobia PM (J05AX29 Fostemsavir) | prescription (Rx) |
| Sunlenca (J05AX31 Lenacapavir) | prescription (Rx) |
| Tpoxx PM (J05AX24 Tecovirimat) | prescription (Rx) |
| Waymade-Maraviroc (J05AX09 Maraviroc) | prescription (Rx) |
| Xofluza PM (J05AX25 Baloxavir marboxil) | prescription (Rx) |
| Yeytuo PM (J05AX31 Lenacapavir) | prescription (Rx) |
Other classes of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05AP Antivirals for treatment of HCV infections 16 drugs
- J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
Other names of the drug class
- Czech: J05AX Jiná antivirotika
- English (United Kingdom): J05AX Other antivirals
- French: J05AX autres antiviraux
- German: J05AX Andere antivirale Mittel
- Spanish: J05AX Otros antivirales (sistemicos)
- German (Austria): J05AX Andere antivirale Mittel
- Italian: J05AX ALTRI ANTIVIRALI
- Polish: J05AX Inne środki antywirotyczne
- Turkish: J05AX ATC'deki diğer antiviraller
- Portuguese (Brazil): J05AX Outros anti-víricos
- Slovak: J05AX Iné antivirotiká
- German (Switzerland): J05AX Andere antivirale Mittel
- French (Switzerland): J05AX Autres antiviraux
- Italian (Switzerland): J05AX Altri antivirali
- Dutch: J05AX Overige antivirale middelen
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AX
Ask your doctor or pharmacist for advice.